Richard Hébert
Impact in
- Nephrology top 1%
- Chronic Kidney Disease and Diabetes
- Biochemistry top 0.5%
- Eicosanoids and Hypertension Pharmacology
Papers in
-
- Ion Transport and Channel Regulation 19
- Receptor Mechanisms and Signaling 11
- Physiology 30
- Nitric Oxide and Endothelin Effects 12
- Smoking Behavior and Cessation 12
- Co-authors
- Rania Nasrallah (33 shared papers)Rhian M. Touyz (9 shared papers)Mona Sedeek (5 shared papers)Matthew D. Breyer (11 shared papers)C. Kennedy (21 shared papers)H R Jacobson (4 shared papers)Kevin D. Burns (12 shared papers)John P. Bent (5 shared papers)
- Journals
- American Journal of Physiology-Renal Physiology (22 papers)Nicotine & Tobacco Research (12 papers)Clinical Science (5 papers)Prostaglandins Leukotrienes and Essential Fatty Acids (4 papers)Canadian Journal of Physiology and Pharmacology (3 papers)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Richard Hébert
103 papers receiving 3.6k citations
Peers
Comparison fields: 5 of 120
- Nephrology 600
- Biochemistry 481
- Clinical Biochemistry 253
- Otorhinolaryngology 139
- Pharmacology 552
Countries citing papers authored by Richard Hébert
This map shows the geographic impact of Richard Hébert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Hébert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Hébert more than expected).
Fields of papers citing papers by Richard Hébert
This network shows the impact of papers produced by Richard Hébert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Hébert. The network helps show where Richard Hébert may publish in the future.
Co-authors
The 25 scholars most cited alongside Richard Hébert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 106 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 400 | |
| 2 | 2010 | 337 | |
| 3 | 2009 | 143 | |
| 4 | 2012 | 142 | |
| 5 | 1998 | 126 | |
| 6 | 1991 | 115 | |
| 7 | 1990 | 115 | |
| 8 | 1998 | 111 | |
| 9 | 1993 | 110 | |
| 10 | 2012 | 102 | |
| 11 | 2009 | 97 | |
| 12 | 1998 | 88 | |
| 13 | 1992 | 84 | |
| 14 | 2015 | 83 | |
| 15 | 1978 | 81 | |
| 16 | 2018 | 80 | |
| 17 | 2005 | 79 | |
| 18 | 2007 | 76 | |
| 19 | 1992 | 70 | |
| 20 | 1999 | 68 |
About Richard Hébert
Richard Hébert is a scholar working on Molecular Biology, Physiology, Pharmacology, Biochemistry and Pulmonary and Respiratory Medicine, having authored 106 papers that have together received 3.7k indexed citations. Recurring topics across this work include Ion Transport and Channel Regulation (19 papers), Eicosanoids and Hypertension Pharmacology (16 papers), Inflammatory mediators and NSAID effects (14 papers), Nitric Oxide and Endothelin Effects (12 papers), Smoking Behavior and Cessation (12 papers), Electrolyte and hormonal disorders (12 papers), Receptor Mechanisms and Signaling (11 papers) and Neuroendocrine regulation and behavior (8 papers). The work is most often cited by research in Nephrology (600 citations), Biochemistry (481 citations), Clinical Biochemistry (253 citations), Otorhinolaryngology (139 citations) and Pharmacology (552 citations). Richard Hébert has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Rania Nasrallah, Rhian M. Touyz, Mona Sedeek, Matthew D. Breyer, C. Kennedy, H R Jacobson, Kevin D. Burns, John P. Bent, Joseph Zimpelmann and S. P. Nadler. Their work appears in journals such as American Journal of Physiology-Renal Physiology, Nicotine & Tobacco Research, Clinical Science, Prostaglandins Leukotrienes and Essential Fatty Acids and Canadian Journal of Physiology and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.